Roche seeks to acquire Spark for nearly $ 5 billion – In search of alpha

by



[ad_1]

  1. Roche seeks to acquire Spark for nearly $ 5 billion in search of alpha
  2. Roche enters into a purchase agreement with Spark Therapeutics for nearly $ 5 billion The Wall Street Journal
  3. Roche would have signed a $ 5 billion contract with biotech company Spark Therapeutics CNBC
  4. The Swiss pharmaceutical giant Roche would be ready to buy biotech at the origin of the first FDA-approved gene therapy and the most expensive drug in the United States
  5. Roche approaches $ 5 billion to acquire Spark Therapeutics: WSJ Reuters
  6. View full coverage on Google News

[ad_2]

Source link